Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Index- P/E- EPS (ttm)-0.17 Insider Own12.48% Shs Outstand29.13M Perf Week16.89%
Market Cap145.33M Forward P/E63.29 EPS next Y0.07 Insider Trans-0.08% Shs Float27.16M Perf Month35.06%
Income-4.83M PEG- EPS next Q0.01 Inst Own20.70% Short Float3.03% Perf Quarter86.13%
Sales94.37M P/S1.54 EPS this Y91.67% Inst Trans30.81% Short Ratio1.42 Perf Half Y170.12%
Book/sh0.76 P/B5.85 EPS next Y333.33% ROA-10.61% Short Interest0.82M Perf Year135.64%
Cash/sh0.36 P/C12.25 EPS next 5Y38.00% ROE-29.25% 52W Range1.16 - 4.68 Perf YTD134.39%
Dividend Est.- P/FCF- EPS past 5Y44.20% ROI-13.73% 52W High-5.34% Beta1.54
Dividend TTM- Quick Ratio1.60 Sales past 5Y6.03% Gross Margin13.44% 52W Low281.90% ATR (14)0.27
Dividend Ex-Date- Current Ratio2.00 EPS Y/Y TTM80.55% Oper. Margin-3.28% RSI (14)71.36 Volatility8.13% 6.39%
Employees237 Debt/Eq0.61 Sales Y/Y TTM24.58% Profit Margin-5.12% Recom1.00 Target Price7.50
Option/ShortYes / Yes LT Debt/Eq0.50 EPS Q/Q104.98% Payout- Rel Volume0.00 Prev Close4.43
Sales Surprise12.59% EPS Surprise128.57% Sales Q/Q42.88% EarningsNov 11 BMO Avg Volume578.55K Price4.43
SMA2018.22% SMA5020.06% SMA20097.91% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jun-24-19Initiated Piper Jaffray Overweight $10
May-13-19Initiated H.C. Wainwright Buy $11
Nov-08-16Downgrade BofA/Merrill Neutral → Underperform
Mar-01-16Downgrade Stifel Buy → Hold
Aug-13-15Initiated Morgan Stanley Underweight $7
Jan-27-15Reiterated Oppenheimer Outperform $24 → $26
Jan-07-15Initiated Oppenheimer Outperform $24
Aug-14-14Initiated FBR Capital Underperform $6
Dec-19-13Initiated Chardan Capital Markets Buy $22
Nov-06-13Reiterated Summer Street Research Buy
Today 07:21AM
Nov-08-24 07:06AM
06:00AM
Oct-17-24 12:00PM
Oct-14-24 06:00AM
05:33PM Loading…
Oct-09-24 05:33PM
Sep-20-24 09:15AM
Sep-18-24 06:00AM
Sep-09-24 12:00PM
08:50AM
06:00AM
Sep-04-24 09:15AM
Sep-03-24 06:00AM
Aug-19-24 09:15AM
Aug-15-24 08:50AM
07:15AM Loading…
Aug-08-24 07:15AM
06:13AM
06:00AM
Aug-07-24 06:00AM
Jul-15-24 06:45AM
Jul-11-24 06:00AM
May-30-24 06:00AM
May-15-24 08:19AM
03:01AM
12:37AM
May-14-24 10:54AM
07:15AM
06:11AM
06:00AM
Apr-17-24 06:00AM
06:00AM Loading…
Apr-16-24 06:00AM
Apr-04-24 06:00AM
Mar-26-24 06:15PM
Mar-25-24 06:00AM
Mar-22-24 09:52AM
Mar-21-24 09:39PM
10:53AM
07:10AM
06:18AM
06:00AM
Mar-11-24 06:15PM
Mar-05-24 06:00PM
Feb-27-24 06:00PM
Feb-20-24 06:00PM
Feb-14-24 06:00PM
Feb-08-24 06:00AM
Jan-08-24 07:30AM
Nov-15-23 01:29PM
Nov-14-23 10:36PM
07:15AM
06:06AM
06:00AM
Nov-07-23 06:00PM
Oct-26-23 06:00PM
Oct-20-23 06:15PM
Oct-18-23 06:00AM
Oct-17-23 06:00AM
Oct-16-23 06:00AM
Oct-13-23 06:15PM
Oct-03-23 06:15PM
06:00AM
Sep-28-23 06:00AM
Sep-27-23 06:15PM
Sep-21-23 06:15PM
06:30AM
Sep-18-23 11:37AM
Sep-07-23 06:00AM
Aug-15-23 12:29PM
Aug-14-23 10:53PM
06:08AM
06:00AM
Aug-11-23 10:28AM
Aug-10-23 10:00AM
Aug-09-23 06:00AM
Aug-01-23 06:25PM
Jul-26-23 06:00PM
Jul-21-23 06:15PM
Jul-17-23 06:00AM
Jul-12-23 10:00AM
06:10AM
Jul-11-23 06:00AM
Jul-03-23 09:35AM
08:50AM
Jun-29-23 06:00AM
Jun-28-23 09:26AM
Jun-27-23 12:00PM
Jun-26-23 06:00AM
Jun-23-23 07:43AM
Jun-20-23 06:09AM
Jun-19-23 08:50AM
Jun-08-23 10:18AM
Jun-01-23 08:50AM
May-15-23 08:55PM
07:15AM
06:07AM
06:00AM
May-11-23 08:50AM
May-01-23 06:00AM
Apr-27-23 06:00AM
Apr-25-23 08:50AM
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chole TimothySVP, Chief Commercial OfficerOct 01 '24Sale3.691,0013,68955,171Oct 02 09:55 PM
Strobeck MarkPresident and CEOOct 01 '24Sale3.692,1637,971147,201Oct 02 09:54 PM
Strobeck MarkOfficerOct 01 '24Proposed Sale3.652,1637,900Oct 01 02:05 PM
Chole TimothyOfficerOct 01 '24Proposed Sale3.601,0013,600Oct 01 01:36 PM